Titlebook: Management of Anemia; A Comprehensive Guid Robert Provenzano,Edgar V. Lerma,Lynda Szczech Book 2018 Springer Science+Business Media LLC 201

澄清

Current and Novel Drugs for Management of Anemia,on with adverse outcomes irrespective of its cause underscores the importance of anemia. Therapeutic strategies to correct anemia range from replacement of red blood cells in the form of blood transfusions to various medical interventions designed to correct the underlying pathophysiology of low blo

Flinch

occurrence

OCTO

昏迷狀態(tài)

Anemia in Malignancy,e of particular chemotherapy regimens. In addition to its impact on quality of life, anemia in cancer patients appears to promote tumor growth, impair response to treatment, and give rise to treatment-resistant tumor-cell clones. The pathophysiology of anemia in malignancy is complex and may be rela

Little

Intend

Post-Transplant Anemia,ses, including blood loss, nutrient deficiency, and bone marrow suppression resulting from transplant medications or opportunistic infections. In addition, some transplant medications are associated with different morphologic types of anemia, including microcytic, macrocytic, or sideroblastic anemia

Ambulatory

,Special Populations with Anemia: Anemia in the?Pediatric Patient,ation, anemia is defined as a pathological reduction in the hemoglobin or hematocrit to a value more than two standard deviations below the mean for age and sex. It can impact the quality of life by causing fatigue, lethargy, headache, reduced exercise capacity, and increased hospitalization. Iron d

ATOPY

Management of Sickle Cell Anemia,chain produces a mutant hemoglobin molecule called hemoglobin S which polymerizes leading to rigid, deformed erythrocytes that in turn lead to vascular occlusion. Therefore, patients experience recurrent episodes of vaso-occlusion crisis resulting in progressive end-organ damage. The mainstay manage

標(biāo)準(zhǔn)